Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein–Related Measures
Circulation: Cardiovascular Genetics · 2015-10 · 8 (5) · 688-695
DOI: 10.1161/circgenetics.114.000962 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Genetics, 2015-10. Verfasst von Audrey Y Chu und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Preventive Medicine (A.Y.C., F.G., S.M., P.M.R., D.I.C.), Division of Cardiovascular Medicine (S.M., P.M.R.), Division of Geneti…. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background— Statin therapy influences not only low-density lipoprotein (LDL) cholesterol levels but also LDL-related biomarkers, including non–high-density lipoprotein cholesterol (non–HDL-C), apolipoprotein B, total number of LDL particles, and mean LDL particle size. Recent studies have identified many genetic loci influencing circulating lipid levels and statin-induced LDL cholesterol reduction. However, it is unknown how these genetic variants influence statin-induced changes in LDL subfractions and non–HDL-C. Methods and Results— One hundred sixty candidate single-nucleotide polymorphisms for effects on circulating lipid levels or statin-induced LDL-cholesterol lowering were tested for association with response of LDL subfractions and non–HDL-C to rosuvastatin or placebo for 1 year among 7046 participants from the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Of the 51 single-nucleotide polymorphisms associated with statin response for ≥1 of the LDL subfractions or non–HDL-C, 20 single-nucleotide polymorphisms could be clustered according to effects predominantly on LDL particle size, predominantly on LDL particle number, and on apolipoprotein B but not on LDL cholesterol or non–HDL-C. Conclusions— These differential associations point to pathways of LDL response to statin therapy and possibly to mechanisms of statin-dependent cardiovascular disease risk reduction. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00239681.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- From the Division of Preventive Medicine (A.Y.C., F.G., S.M., P.M.R., D.I.C.), Division of Cardiovascular Medicine (S.M., P.M.R.), Division of Genetics (D.I.C.), Brigham and Women's Hospital and Harvard Medical School,…
Förderung
- NHLBI NIH HHS
Zitieren
APA
Chu, A. Y., Giulianini, F., Barratt, B. J., Ding, B., Nyberg, F., Mora, S., Ridker, P. M., & Chasman, D. I. (2015). Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein–Related Measures. Circulation: Cardiovascular Genetics, 8(5), 688-695. https://doi.org/10.1161/circgenetics.114.000962
Vancouver
Chu AY, Giulianini F, Barratt BJ, Ding B, Nyberg F, Mora S, et al. Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein–Related Measures. Circulation: Cardiovascular Genetics. 2015;8(5):688-695. doi:10.1161/circgenetics.114.000962
BibTeX
@article{Chu2015,
author = {Chu, Audrey Y and Giulianini, Franco and Barratt, Bryan J and Ding, Bo and Nyberg, Fredrik and Mora, Samia and Ridker, Paul M and Chasman, Daniel I},
title = {Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein–Related Measures},
journal = {Circulation: Cardiovascular Genetics},
year = {2015},
volume = {8},
number = {5},
pages = {688--695},
doi = {10.1161/circgenetics.114.000962}
}
EUVIMED